Detalhe da pesquisa
1.
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Blood
; 139(16): 2499-2511, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995350
2.
Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.
Radiology
; 295(3): 651-661, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286191
3.
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.
Haematologica
; 108(10): 2814-2819, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891749
4.
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
Ann Hematol
; 97(12): 2391-2401, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091022
5.
Rituximab-Lenalidomide-Ibrutinib Combination for Relapsed/Refractory Primary CNS Lymphoma: A Case Series of the LOC Network.
Neurology
; 97(13): 628-631, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580183
6.
Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement.
Cancers (Basel)
; 13(12)2021 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204600
7.
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Blood Adv
; 5(2): 539-548, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496747
8.
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Blood Adv
; 5(19): 3862-3872, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461634
9.
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.
Leukemia
; 35(9): 2672-2683, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658659
10.
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström's macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica
; 95(6): 950-5, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20081058
11.
Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab.
J Nucl Med
; 61(5): 649-654, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628220
12.
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
Neurology
; 94(10): e1027-e1039, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907289
13.
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.
Eur J Cancer
; 115: 47-56, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31082693
14.
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
Neuro Oncol
; 18(9): 1297-303, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951382
15.
Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Leuk Lymphoma
; 54(1): 76-82, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22680774
16.
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Cancer
; 116(17): 4054-62, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564152
17.
Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis.
Thromb Res
; 126(5): e394-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20825981